How often should long-term arthritis medication be reviewed?Â
In the UK, the frequency of medication reviews for long-term arthritis treatment depends on the specific drug you are taking and how stable your condition has become. Because medications for conditions like Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PsA) work by modulating the immune system, they require a two-tier monitoring system: frequent blood tests for safety and periodic clinical reviews for effectiveness. The goal is to ensure you are on the lowest effective dose while preventing joint damage and minimizing side effects.
What We’ll Discuss in This Article
- The difference between safety blood monitoring and clinical reviewsÂ
- Standard review timelines for DMARDs and BiologicsÂ
- The role of the Annual Arthritis ReviewÂ
- Identifying when you need an unscheduled medication reviewÂ
- Who conducts the reviews: GPs vs. RheumatologistsÂ
- Factors that may increase the frequency of your check-upsÂ
For most patients in the UK, long-term arthritis medication is reviewed clinically at least once or twice a year, though blood monitoring occurs much more frequently. These reviews are essential for checking that the treatment is still working and that your internal organs, such as your liver and kidneys, are handling the medication safely. The NHS emphasizes that regular reviews are necessary to monitor the progress of your condition and ensure that any side effects are identified and managed early.
Safety Blood Monitoring Frequency
Before a clinical review even takes place, you will undergo regular blood tests. This is often called safety monitoring. When you first start a new Disease-Modifying Anti-Rheumatic Drug (DMARD) like methotrexate, the monitoring is very frequent.2
Initiation Phase
Usually every 2 weeks for the first 6 to 12 weeks.
Stable Phase
Once your dose is steady and your blood counts are normal, this typically moves to every 3 months.
These tests check your Full Blood Count (FBC) to ensure your white blood cells remain at a healthy level to fight infection, and your Liver Function Tests (LFTs) to ensure the medication isn’t causing stress to your liver.
Clinical Effectiveness Reviews
A clinical review is a face-to-face or telephone consultation where a specialist or GP assesses how well the drug is controlling your arthritis.
Biologic Treatments
If you are on a biologic therapy, NICE guidelines usually require a review every 6 months to ensure the drug still meets the criteria for NHS funding.
Stable DMARDs
If your symptoms are well-controlled on standard tablets, you may only need a formal clinical review once a year.
The Annual Review
This is a comprehensive check-up that covers not just your joints, but also your heart health, bone density, and mental wellbeing.
When to Seek an Unscheduled Review
You should not wait for your scheduled appointment if you notice significant changes in your health. An urgent review is necessary if:
The “Flare” Pattern Changes
Your usual pain relief isn’t working or flares are becoming more frequent.
Signs of Infection
You develop a high fever, persistent cough, or other infections, as your medication may need to be paused.
New Side Effects
You experience unexplained bruising, a severe skin rash, or yellowing of the skin or eyes.
Planning Pregnancy
Many arthritis medications must be reviewed and changed well before you attempt to conceive.
Who Performs the Review?
In the UK, the responsibility for reviews is often shared. Your specialist rheumatology team usually conducts the high-level clinical reviews and decides on dose changes. However, many GP surgeries take over the routine blood monitoring and issuing of prescriptions once you are on a stable dose. This is known as a Shared Care Agreement.
| Treatment Type | Primary Reviewer | Typical Blood Test Frequency |
| New Medication | Rheumatologist | Every 2 weeks |
| Stable DMARDs | GP / Rheumatology Nurse | Every 3 months |
| Biologic Therapy | Rheumatology Consultant | Every 3 to 6 months |
| Steroids (Oral) | GP / Rheumatologist | Monthly to 3-monthly |
Conclusion
Regular medication reviews are the safety net of arthritis care in the UK. By attending your blood tests every three months and participating in your annual clinical review, you ensure that your treatment remains both safe and effective. This proactive approach is the best way to maintain long-term joint health and overall systemic wellbeing. If you experience sudden, severe side effects or a significant worsening of your condition, contact your rheumatology advice line or call 999 in an emergency.
Can I skip a blood test if I feel fine?Â
No. Many side effects, especially those affecting the liver or blood counts, do not have outward symptoms until they are advanced.3 Regular tests are the only way to catch these early.Â
Why does my biologic require a review every 6 months?Â
Biologics are high-cost treatments.4 NHS guidelines require consultants to prove the drug is still providing a significant clinical benefit to continue funding.Â
What is a Shared Care Agreement?Â
It is a formal arrangement where your specialist provides the expertise and the GP handles the practicalities of prescriptions and routine blood monitoring.Â
Can a pharmacist review my medication?Â
A clinical pharmacist can check for drug interactions and help with adherence, but they cannot usually change your arthritis specialist medication without consulting your rheumatologist.
What happens if I miss my review?Â
In many cases, the GP or hospital may stop issuing prescriptions if a safety review or blood test is overdue. This is to ensure you aren’t taking medication that could be harmful.Â
Will my dose be lowered if I’m in remission?Â
If you have been in deep remission for a long time, your consultant may discuss tapering your dose during a review to find the lowest amount needed to keep you stable.Â
Do I need a review if I stop my medication?Â
Yes. You should never stop long-term arthritis medication without a clinical review, as this can lead to severe flares and permanent joint damage
Authority Snapshot (E-E-A-T Block)
This evidence-based guide follows UK clinical standards for medication monitoring, drawing from the NHS, NICE, and the British Society for Rheumatology. The content is authored by the Medical Content Team and reviewed by Dr. Rebecca Fernandez, a UK-trained physician with experience in internal medicine and emergency care. Our goal is to provide safe, factual, and practical information for patients managing long-term treatments.
